These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7726715)

  • 1. A longitudinal study of symptom dimensions in schizophrenia. Prediction and patterns of change.
    Arndt S; Andreasen NC; Flaum M; Miller D; Nopoulos P
    Arch Gen Psychiatry; 1995 May; 52(5):352-60. PubMed ID: 7726715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimensions and subtypes of recent-onset schizophrenia. A longitudinal analysis.
    Willem Van der Does AJ; Dingemans PM; Linszen DH; Nugter MA; Scholte WF
    J Nerv Ment Dis; 1995 Nov; 183(11):681-7. PubMed ID: 7595429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective longitudinal 10-year study of schizophrenia's three major factors and depression.
    Marengo J; Harrow M; Herbener ES; Sands J
    Psychiatry Res; 2000 Dec; 97(1):61-77. PubMed ID: 11104858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Iowa Longitudinal Study of Recent Onset Psychosis: one-year follow-up of first episode patients.
    Gupta S; Andreasen NC; Arndt S; Flaum M; Hubbard WC; Ziebell S
    Schizophr Res; 1997 Jan; 23(1):1-13. PubMed ID: 9050123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the course of persistent symptoms in schizophrenia: Longitudinal findings from the pattern study.
    Haro JM; Altamura C; Corral R; Elkis H; Evans J; Krebs MO; Zink M; Malla A; Méndez JI; Bernasconi C; Lalonde J; Nordstroem AL
    Psychiatry Res; 2018 Sep; 267():56-62. PubMed ID: 29883861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight dimensions and cognitive function in psychosis: a longitudinal study.
    Cuesta MJ; Peralta V; Zarzuela A; Zandio M
    BMC Psychiatry; 2006 May; 6():26. PubMed ID: 16737523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up.
    Milev P; Ho BC; Arndt S; Andreasen NC
    Am J Psychiatry; 2005 Mar; 162(3):495-506. PubMed ID: 15741466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dimensions of schizophrenic symptomatology. Comparative testing of several theoretical models in a first-episode population sample].
    Löffler W; Häfner H
    Nervenarzt; 1999 May; 70(5):416-29. PubMed ID: 10407837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiating primary from secondary negative symptoms in schizophrenia: a study of neuroleptic-naive patients before and after treatment.
    Peralta V; Cuesta MJ; Martinez-Larrea A; Serrano JF
    Am J Psychiatry; 2000 Sep; 157(9):1461-6. PubMed ID: 10964863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-year outcome in first-episode schizophrenia: predictive value of symptoms for quality of life.
    Ho BC; Nopoulos P; Flaum M; Arndt S; Andreasen NC
    Am J Psychiatry; 1998 Sep; 155(9):1196-201. PubMed ID: 9734542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative, psychoticism, and disorganized dimensions in patients with familial schizophrenia or bipolar disorder: continuity and discontinuity between the major psychoses.
    Maziade M; Roy MA; Martinez M; Cliche D; Fournier JP; Garneau Y; Nicole L; Montgrain N; Dion C; Ponton AM
    Am J Psychiatry; 1995 Oct; 152(10):1458-63. PubMed ID: 7573584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptoms of schizophrenia. Methods, meanings, and mechanisms.
    Andreasen NC; Arndt S; Alliger R; Miller D; Flaum M
    Arch Gen Psychiatry; 1995 May; 52(5):341-51. PubMed ID: 7726714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term course and outcome in schizophrenia: a 34-year follow-up study in Alberta, Canada.
    Newman SC; Bland RC; Thompson AH
    Psychol Med; 2012 Oct; 42(10):2137-43. PubMed ID: 23206379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of schizophrenia subtypes. II. Positive and negative symptoms and long-term course.
    Fenton WS; McGlashan TH
    Arch Gen Psychiatry; 1991 Nov; 48(11):978-86. PubMed ID: 1747021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome.
    Breier A; Schreiber JL; Dyer J; Pickar D
    Arch Gen Psychiatry; 1991 Mar; 48(3):239-46. PubMed ID: 1671741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of symptom remission in schizophrenia during inpatient treatment.
    Jäger M; Riedel M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Kühn KU; Lemke MR; Rüther E; Buchkremer G; Gastpar M; Bottlender R; Strauss A; Möller HJ
    World J Biol Psychiatry; 2009; 10(4 Pt 2):426-34. PubMed ID: 17853260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychopathological dimensions in schizophrenia.
    Cuesta MJ; Peralta V
    Schizophr Bull; 1995; 21(3):473-82. PubMed ID: 7481577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptom structure in schizophrenia: two-, three- or four-factor models?
    Dollfus S; Everitt B
    Psychopathology; 1998; 31(3):120-30. PubMed ID: 9636941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latent structures underlying schizophrenic symptoms: a five-dimensional model.
    Nakaya M; Suwa H; Ohmori K
    Schizophr Res; 1999 Aug; 39(1):39-50. PubMed ID: 10480666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients.
    Szymanski S; Lieberman JA; Alvir JM; Mayerhoff D; Loebel A; Geisler S; Chakos M; Koreen A; Jody D; Kane J
    Am J Psychiatry; 1995 May; 152(5):698-703. PubMed ID: 7726309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.